Fagron Acquires Purifarma in Brazil

Fagron Acquires Purifarma (Brazil)

January 6, 2026

Pharmaceuticals

Fagron has completed the acquisition of Purifarma in Brazil following CADE approval, strengthening Fagron's scale in Essentials and advancing its buy-and-build strategy. Purifarma is a large-scale distributor/importer of pharmaceutical, food and cosmetic inputs; the transaction carries an enterprise value of approximately R$250 million and is expected to deliver product-mix improvements, access to industrial customers and purchasing synergies across Latin America.

Fagron Acquires University Compounding Pharmacy (UCP)

January 12, 2026

Pharmaceuticals

Fagron NV has completed the acquisition of University Compounding Pharmacy (UCP), a San Diego–based 503A compounding pharmacy focused on health and wellness, hormones and urology. The transaction has an enterprise value of approximately $41.5 million; UCP had annual revenues of around $25 million and will be integrated to strengthen Fagron's U.S. compounding platform alongside Anazao, with synergies expected over 18–24 months.

AvevoRx Acquires Infupharma to Expand Specialty Infusion Presence in Florida

April 1, 2024

Healthcare Services

AvevoRx, an independent specialty infusion pharmacy provider headquartered in Greensboro, North Carolina, has acquired Hollywood, Florida–based Infupharma, Inc. (retail operations known as Global View Pharmacy), effective April 1, 2024. The deal gives AvevoRx its first presence in Florida, expanding geographic reach, payor access, and specialty infusion and compounding capabilities for patients in the state.

PerkinElmer Acquires Project Farma from Precision for Medicine

March 11, 2025

Healthcare Services

PerkinElmer has acquired Project Farma, a life‑sciences technical operations consultancy and subsidiary of Precision for Medicine, to expand its OneSource professional services offering. The acquisition brings Project Farma’s engineering, commissioning/qualification, project management and GMP facility experience into PerkinElmer’s lab services portfolio; terms were not disclosed.

Fagron Completes Acquisition of University Compounding Pharmacy (UCP)

January 12, 2026

Pharmaceuticals

Fagron has completed the acquisition of University Compounding Pharmacy (UCP), a San Diego–based 503A compounding pharmacy focused on hormone and urology therapies. The transaction values UCP at approximately $41.5 million; UCP generates roughly $25 million of annual revenue. Fagron said the purchase supports its strategy to build a nationwide U.S. compounding platform (complementary to Anazao) and strengthens its presence in California.

BRANDED Group Acquires Puracy

October 6, 2021

Consumer Products

BRANDED Group has completed the full acquisition of Puracy, a plant-based household cleaning and personal care brand founded in 2013. The deal pairs Puracy's natural-product portfolio and founder team with BRANDED's e-commerce infrastructure and resources to accelerate brand growth and global expansion.